Project Details
Description
Selumetinib Treatment for Pediatric Patients in the United States (US) with Neurofibromatosis Type 1 (NF1) with Plexiform Neurofibromas (PN): A Retrospective Cohort Study; D134BR00002
Status | Active |
---|---|
Effective start/end date | 10/23/24 → 10/22/35 |
Funding
- ALEXION PHARMACEUTICALS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.